Preclinical models that illuminate the bone metastasis cascade.

Area of Science:

• Oncology
• Cancer Metastasis Research
• Preclinical Animal Models

Background:

• Bone metastasis is a complex, multistep process that significantly impacts patient outcomes.
• Understanding the mechanisms of bone metastasis is critical for developing effective therapeutic strategies.
• Current research relies on various preclinical models to study tumor progression and metastatic behavior.

Purpose of the Study:

• To describe available preclinical models for tumor progression and bone metastasis.
• To highlight the role of novel imaging technologies in advancing bone metastasis research.
• To underscore the importance of these models and technologies in developing new cancer treatments.

Main Methods:

• Description of genetically engineered mouse models that develop primary and metastatic carcinomas.
• Utilization of transplantable animal models for studying bone metastasis.
• Application of advanced imaging techniques, particularly optical imaging, in preclinical settings.

Main Results:

• Preclinical models provide essential platforms for investigating the cellular behavior of osteotropic tumors.
• Novel imaging technologies facilitate the study of cancer and its surrounding stroma.
• Optical imaging has proven valuable in preclinical bone metastasis models and clinical trials.

Conclusions:

• Effective preclinical models are fundamental for understanding and combating bone metastasis.
• Advancements in imaging technologies are enhancing the study of cancer progression and treatment response.
• Continued development in imaging and preclinical models promises improved diagnosis, localization, drug delivery, and treatment for bone metastasis.